Condition
Peri-anal Fistulas
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed2
Withdrawn1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01828190Not ApplicableCompleted
The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers
NCT03904212Phase 2Unknown
Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease
NCT01635543Withdrawn
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
NCT01462747Phase 2CompletedPrimary
Efficacy and Safety Study of a Medical Device (KULIST)to Treat Perianal Fistulas
Showing all 4 trials